Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy. uri icon

Overview

publication date

  • August 18, 2021

Identity

PubMed Central ID

  • PMC8413661

Scopus Document Identifier

  • 85122699646

Digital Object Identifier (DOI)

  • 10.1016/j.jdcr.2021.08.005

PubMed ID

  • 34504927

Additional Document Info

volume

  • 16